About Ahn-Gook Pharmaceutical
Ahn-Gook Pharmaceutical is a company based in Seoul (South Korea) founded in 1955. The company has 420 employees as of December 31, 2024. Ahn-Gook Pharmaceutical operates in a competitive market with competitors including AmerisourceBergen, Taejeon Group and Nexus Pharma, among others.
- Headquarter Seoul, South Korea
- Employees 420 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ahn-Gook Pharmaceutical Co., Ltd.
-
Annual Revenue
$183.82 M (USD)16.02as on Dec 31, 2024
-
Net Profit
$11.42 M (USD)1205.72as on Dec 31, 2024
-
EBITDA
$9.7 M (USD)49.77as on Dec 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
420
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ahn-Gook Pharmaceutical
Ahn-Gook Pharmaceutical is a publicly listed company on the KRX with ticker symbol 001540 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Ahn-Gook Pharmaceutical
Investors in Ahn-Gook Pharmaceutical
Ahn-Gook Pharmaceutical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Lindeman Asia Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of a venture capital and private equity investing across multiple sectors
|
Locked | Locked | Locked |
Investor details for Ahn-Gook Pharmaceutical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ahn-Gook Pharmaceutical
Investment portfolio details for Ahn-Gook Pharmaceutical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ahn-Gook Pharmaceutical
Detailed financials for Ahn-Gook Pharmaceutical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ahn-Gook Pharmaceutical Comparisons
Peer comparison for Ahn-Gook Pharmaceutical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ahn-Gook Pharmaceutical
Ahn-Gook Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Taejeon Group and Nexus Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Distributes a variety of pharmaceutical drugs.
|
|
| Locked | Locked | Locked |
Manufactures pharmaceuticals, cosmeceuticals, skincare, and distributes globally to partners and clinics.
|
Detailed competitors of Ahn-Gook Pharmaceutical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ahn-Gook Pharmaceutical
Complete news archive for Ahn-Gook Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ahn-Gook Pharmaceutical
Ahn-Gook Pharmaceutical was founded in 1955 and raised its 1st funding round 56 years after it was founded.
Ahn-Gook Pharmaceutical is headquartered in Seoul, South Korea.
Jin Auh is the current CEO of Ahn-Gook Pharmaceutical.
As of Dec 31, 2024, the latest employee count at Ahn-Gook Pharmaceutical is 420.
Annual revenue of Ahn-Gook Pharmaceutical is $183.82M as on Dec 31, 2024.
Ahngook Pharm is engaged in manufacturing and marketing of pharmaceutical products. Products offered include Tobicom S, Sinecura syrup, Annecor capsules, levotensin tablets, digestive system, osteoarthritis, etc.
Ahn-Gook Pharmaceutical's top competitors include AmerisourceBergen, Taejeon Group and Nexus Pharma.
Yes, Ahn-Gook Pharmaceutical is publicly traded on KRX under the ticker symbol 001540.
Ahn-Gook Pharmaceutical has 1 investor. Key investors include Lindeman Asia Investment.
The ticker symbol of Ahn-Gook Pharmaceutical is 001540 on KRX.